Parabilis Medicines Inc.

PBLS | NASDAQ

Price Alert Chart Builder DCF Calculator

$28.32

-$0.38 (-1.32%)

At close: Oct 30, 2026, 4:00 PM ET

$28.53

+$0.21 (+0.74%)

Pre-market: Nov 2, 2026, 7:53 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $3.45B

Enterprise Value $2.38B

Beta 5.03

Average Volume 773.43K

Shares Outstanding (Diluted) 28.91M

Shares Change YoY N/A

Institutional Ownership N/A

Exchange NASDAQ

ISIN US6989551014

Price Performance

Price Change 1M -12.3%

Price Change 3M -16.7%

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -32.1%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR 141.5%

Valuation

PE Ratio -0.77

Forward PE N/A

PEG Ratio 0.11

Forward PEG 0.03

PS Ratio 23,335.69

Forward PS 383.70

PB Ratio 3.30

P/FCF Ratio -64.19

P/Adj. FCF Ratio -58.79

P/OCF Ratio -15.48

EV/Sales 16,084.44

EV/EBIT -24.47

EV/EBITDA -24.78

EV/FCF -44.24

Earnings Yield -130.3%

FCF Yield -1.6%

Adj. FCF Yield -1.7%

Financial Health

Net Cash $1.11B

Total Debt $47.51M

Cash & Short-Term Investments $1.12B

Total Assets $1.18B

Current Ratio 17.91

Quick Ratio 17.91

Debt / Equity Ratio 0.05

Debt / EBITDA -0.49

Debt / FCF -0.88

OCF / Debt -1.11

Interest Coverage -195.89

Altman Z-Score 16.30

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 100.0%

Operating Profit Margin -66445.3%

EBITDA Margin -64917.6%

Net Profit Margin -66066.9%

FCF Margin -36356.1%

Adj. FCF Margin -39692.6%

SBC / Revenue 3336.5%

SBC Impact (per share) -9.2%

Returns

Return on Assets -8.3%

Return on Equity -15.1%

Return on Invested Capital -8.7%

Return on Capital Employed -8.8%

Return on Tangible Assets -8.3%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$0.40

EPS Growth Est (next Q) N/A

Revenue Est (next Q) $375K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $40.00

Price Target Upside 41.2%

Cash Flow

Operating Cash Flow $-52.82M

Free Cash Flow $-53.81M

Adj. Free Cash Flow $-58.75M

FCF Per Share -$1.86

OCF Per Share -$1.83

OCF/S Ratio -35690.5%

Income Statement

Revenue $148K

Gross Profit $148K

Operating Income $-98.34M

EBITDA $-96.08M

Net Income $-97.78M

EPS (Diluted) -$36.90

Revenue / Employee $1.02K

Profit / Employee $-674.34K

Employees 145